The use of Multidimensional Data to Identify the Molecular Biomarker for Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease, and the patient has an extremely poor overall survival with a less than 5% 5-year survival rate. Development of potential biomarkers provides a critical foundation for the diagnosis of PDAC. In this project, we have adopted an integrative...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Liwei, Qi, Yue, Wu, Yun, Liu, Nannan, Fu, Yili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793503/
https://www.ncbi.nlm.nih.gov/pubmed/24171174
http://dx.doi.org/10.1155/2013/798054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793503/
https://www.ncbi.nlm.nih.gov/pubmed/24171174
http://dx.doi.org/10.1155/2013/798054

Ejemplares similares